Royal DSM reorganizes; 1,000 jobs cut

Wednesday, August 26, 2015

Royal DSM, a global life sciences and materials sciences company, has made adjustments to its organizational and operating model, including a reduction in headcount of 900 to 1,100, half of which will occur in the Netherlands. Those cuts will be fully implemented by the end of 2017.

[Read More]

New Norway Innovation Park opens

Monday, August 24, 2015

The Oslo Cancer Cluster Innovation Park in Norway has opened. A $122.8 million, public-private investment, the Innovation Park brings together the research, healthcare and industry partners in the Oslo oncology value chain with the Ullern High School.

[Read More]

Report: U.K. biotech pulling ahead in Europe

Monday, July 27, 2015

Over the past 10 years, the U.K. biotech sector has outperformed other European countries, raising $1.4 billion via IPOs and $2.4 billion in venture capital, according to a new report from life science market intelligence firm Evaluate and the U.K. BioIndustry Association (BIA). The rise in optimism has been most evident in 2014, with the momentum continuing into 2015.

[Read More]